Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 5 Feb 20 EFFECT Notice of effectiveness
- 4 Feb 20 424B3 Prospectus supplement
- 3 Feb 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 3 Feb 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
22 Jan 20 S-4 Registration of securities issued in business combination transactions
CATC similar filings
- 27 Jun 22 Registration of securities issued in business combination transactions
- 3 Feb 20 Registration of securities issued in business combination transactions (amended)
- 3 Feb 20 Registration of securities issued in business combination transactions (amended)
- 22 Jan 20 Registration of securities issued in business combination transactions
- 1 Feb 19 Registration of securities issued in business combination transactions (amended)
- 22 Jan 19 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 99.3
Consent of Director Nominee
In accordance with Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named as a person who will become a director of Cambridge Bancorp (“Cambridge”) pursuant to the terms of the Agreement and Plan of Merger by and among Cambridge, Cambridge Trust Company, Wellesley Bancorp, Inc. and Wellesley Bank, dated as of December 5, 2019, in the joint proxy statement/prospectus that forms a part of the Registration Statement on FormS-4 of Cambridge, and any amendment or supplement thereto (the “Registration Statement”), and to the filing of this consent as an exhibit to the Registration Statement.
/s/ Thomas J. Fontaine | January 22, 2020 | |||||||
Thomas J. Fontaine |
Date |